Potential Mycoplasma Contaminants: Inactivation during Production of Inactivated Egg-Based Viral Vaccines
Dmitriy V. Volokhov, DVM, Ph.D, DACVM, Donna K. F. Chandler, Ph.D, & Vladimir Chizhikov, Ph.D Division of Viral Products Center for Biologics Evaluation and Research, US Food and Drug Administration
Revision of PDA Technical Report Number 33
Michael J. Miller, Ph.D. President, Microbiology Consultants, LLC Jeanne Moldenhauer, Ph.D., Vice President Excellent Pharma Consulting
Monitoring GMP Compliance in an Analytical R&D Laboratory by use of a Peer-Led Program
Peter Tattersall, Ph.D, Michelle Kubin & Anwar Hussain Analytical Research & Development, Bristol-Myers Squibb